Produit
AGENTS IA
APPLICATIONS DE L'IA
AUTRES
Solutions
SECTEURS D'ACTIVITÉ
Tarification
Ressources
EXPLORER
ENGAGER
ASSISTANCE ET SERVICES
À propos
Plateforme PatSnap Eureka
Mandataires en propriété intellectuelle
Agents pour l'ingénierie
Agents pour les sciences de la vie
Agents pour matériaux
Analytique
Intelligence IPSynapse
Renseignement biopharmaceutiqueBiographie
Recherche et analyse de séquences biologiquesChimique
Recherche et analyse de structures chimiquesPlateforme ouverte
Services professionnels
Témoignages clients
Newsroom
Blog
Rapport mondial sur l'innovation
Glossaire
Webinaires et formations
Frontière
Communauté d'utilisateurs
Confiance et sécurité
PatentBench
LLM
Centre d'aide
Carrières
Accès à plus de 2 000 000 000 points de données structurées dans les domaines des brevets, des sciences, des litiges et des technologies.
Innovez 75 % plus vite à un coût réduit de 25 %.
Cloud ou sur site pour une confidentialité et un contrôle maximaux
Reconnu par plus de 18 000 innovateurs à travers le monde
Pour l'utiliser, cliquez sur le bouton de vérification dans l'e-mail que nous avons envoyé à [email protected].
Cela contribue à sécuriser votre compte.
Vous devriez le recevoir sous peu. N'oubliez pas de vérifier votre dossier spam.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Série soigneusement sélectionnée offrant des informations précieuses aux professionnels de l'innovation.
Article | Rapport The 2026 biodegradable agricultural film landscape: PBAT, PLA, degradation engineering, nutrient-delivery films, and emerging IP from China, Japan, Italy & Brazil.
Article | Rapport Explore the high-entropy oxide materials landscape for 2026: synthesis routes, energy storage, electronics applications, and key innovation trends analysed by PatSnap.
Article | Rapport Patent and literature evidence maps hydrogen pipeline material technology in 2026: steel embrittlement, polymer liners, cryogenic LH₂ systems, and infrastructure conversion.
Article | Rapport Certified efficiencies now exceed 32.5% for perovskite/silicon tandems, yet long-term stability remains the key barrier. Explore the 2026 technology landscape.
Article | Rapport How CGM, non-invasive optical sensing, sweat biofluid platforms, and AI analytics are reshaping the wearable glucose monitor landscape in 2026.
Article | Rapport Explore the 2026 anti-corrosion coating technology landscape for marine and infrastructure: key chemistries, patent trends, regulatory drivers, and emerging innovations.
Article | Rapport A 2026 patent and research landscape of electric aircraft motor technology: PMSM, axial-flux, hybrid powertrains, and the IP strategies shaping aviation electrification.
Article | Rapport Mapping bio-based polymers, advanced recycling, and AI-assisted design in sustainable packaging — patent and literature evidence from 2009 to 2026.
Article | Rapport Explore the 2026 solid-state electrolyte materials landscape: sulfide, oxide, and polymer chemistries, key patent trends, and R&D intelligence via PatSnap Eureka.
Article | Rapport A 2026 HVDC technology landscape: converter architectures, cable systems, DC grid protection, and where China, Europe & Korea are filing patents.
Article | Rapport Floating solar PV (FPV) technology landscape 2026: patent trends, offshore frontiers, hybrid systems, and the 404 GWp reservoir opportunity mapped by PatSnap.
Article | Rapport Explore the 2026 SiC power module packaging technology landscape: substrate engineering, wire-bondless interconnects, thermal management, and key patent assignees.
Article | Rapport A deep-dive into the quantum error correction patent landscape 2026: key assignees, emerging LDPC code trends, AI decoders, and strategic IP implications for R&D teams.
Article | Rapport Map the 2026 AI protein structure prediction landscape: AlphaFold2, ESMFold, RoseTTAFold, antibody modeling, and emerging lightweight architectures for drug discovery.
Article | Rapport Nedosiran's FDA approval for primary hyperoxaluria type 1: how Dicerna/Novo Nordisk's LDHA-targeting siRNA competes with lumasiran in the RNAi oxalate space.